Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Novogen Ltd.
DescriptionCyclodextrin envelope containing the cytotoxic small molecule TRXE-002, a dimer of 2 benzopyran rings called a super-benzopyran, designed for intraperitoneal use
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentIND
Standard IndicationOvarian cancer
Indication DetailsTreat ovarian cancer
Regulatory Designation U.S. - Orphan Drug (Treat ovarian cancer)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today